We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.31M
2
AMGN icon
Amgen
AMGN
+$1.97M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.79M
4
TSRO
TESARO, Inc.
TSRO
+$1.56M
5
CLX icon
Clorox
CLX
+$1.3M

Top Sells

1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
251
CALL
Nektar Therapeutics
NKTR
$2.31B
– –
-1,733
Closed -$54K
NKTR icon
252
Nektar Therapeutics
NKTR
$2.31B
– –
-340
Closed -$120K
NKTR icon
253
PUT
Nektar Therapeutics
NKTR
$2.31B
– –
-2,333
Closed -$4K
NVDA icon
254
CALL
NVIDIA
NVDA
$4.91T
– –
-920,000
Closed -$122K
NVDA icon
255
NVIDIA
NVDA
$4.91T
– –
-31,080
Closed -$85K
NVDA icon
256
PUT
NVIDIA
NVDA
$4.91T
– –
-80,000
Closed -$1K
OZK icon
257
CALL
Bank OZK
OZK
$5.68B
– –
-10,000
Closed -$30K
PBYI icon
258
Puma Biotechnology
PBYI
$434M
– –
-6,039
Closed -$338K
PCRX icon
259
Pacira BioSciences
PCRX
$1.01B
– –
-5,000
Closed -$228K
PCRX icon
260
PUT
Pacira BioSciences
PCRX
$1.01B
– –
-5,000
Closed -$72K
PLCE icon
261
CALL
Children's Place
PLCE
$65.8M
– –
-5,000
Closed -$1K
PLCE icon
262
Children's Place
PLCE
$65.8M
– –
-4,600
Closed -$552K
PLCE icon
263
PUT
Children's Place
PLCE
$65.8M
– –
-15,800
Closed -$72K
PPC icon
264
CALL
Pilgrim's Pride
PPC
$6.93B
– –
-4,000
Closed -$5K
PPC icon
265
PUT
Pilgrim's Pride
PPC
$6.93B
– –
-20,500
Closed -$2K
PRGO icon
266
CALL
Perrigo
PRGO
$1.48B
– –
-20,000
Closed -$5K
PRGO icon
267
PUT
Perrigo
PRGO
$1.48B
– –
-19,200
Closed -$459K
PZZA icon
268
Papa John's
PZZA
$1.08B
– –
-1,500
Closed -$119K
PZZA icon
269
PUT
Papa John's
PZZA
$1.08B
– –
-27,000
Closed -$38K
QQQ icon
270
Invesco QQQ Trust
QQQ
$466B
– –
-5,130
Closed -$679K
QQQ icon
271
PUT
Invesco QQQ Trust
QQQ
$466B
– –
-96,800
Closed -$9K
RGLD icon
272
CALL
Royal Gold
RGLD
$16.1B
– –
-20,500
Closed -$99K
RGLD icon
273
PUT
Royal Gold
RGLD
$16.1B
– –
-17,600
Closed -$13K
SAGE
274
CALL
DELISTED
Sage Therapeutics
SAGE
– –
-15,000
Closed -$56K
SFM icon
275
CALL
Sprouts Farmers Market
SFM
$7.13B
– –
-31,100
Closed -$87K
9 10
11
12 13

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.